申请人:Habtemariam Abraha
公开号:US20080096846A1
公开(公告)日:2008-04-24
A ruthenium (II) compound of formula (I): or a solvate on prodrug thereof, wherein: R
1
, R
1
, R
3
, R
4
, R
5
and R
6
are independently selected from H, C
1-7
alkyl, C
5-20
aryl, C
3-20
heterocyclyl, halo, ester, amido, acyl, sulfo, sulfonamido, ether, thioether, azo, amino, or R
1
and R
2
together with the ring to which they are attached form a saturated or unsaturated carbocyclic or heterocyclic group containing up to three 3- to 8-membered carbocyclic or heterocyclic rings, wherein each carbocyclic or heterocyclic ring may be fused to one or more other carbocyclic or heterocyclic rings; X is a neutral or negatively charged N- or S-donor ligand; Y is a counterion; in is 0 or 1; q is 1, 2 or 3; C″ is C
1-12
alkylene bound to two A groups; p is 0 or 1 and r is 1 when p is 0 and r is 2 when p is 1; and A and B are each independently O-donor, N-donor or S-donor ligands, and may be connected to one another. The compounds are used in cancer therapy.